-
1
-
-
0025095646
-
Mastocytoses systémiques et mastocytoses malignes
-
Lortholary O, Casassus P, Larroche L, Lortholary P, Diebold J. Mastocytoses systémiques et mastocytoses malignes. Presse Med 1991;19:125-58.
-
(1991)
Presse Med
, vol.19
, pp. 125-158
-
-
Lortholary, O.1
Casassus, P.2
Larroche, L.3
Lortholary, P.4
Diebold, J.5
-
2
-
-
0024271215
-
Systemic mast cell disease. Analysis of 58 cases and literature review
-
Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 1988;67:345-68.
-
(1988)
Medicine (Baltimore)
, vol.67
, pp. 345-368
-
-
Travis, W.D.1
Li, C.Y.2
Bergstralh, E.J.3
Yam, L.T.4
Swee, R.G.5
-
3
-
-
0034983045
-
Diagnostic criteria and classification of mastocytosis: A consensus proposal
-
Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-25.
-
(2001)
Leuk Res
, vol.25
, pp. 603-625
-
-
Valent, P.1
Horny, H.P.2
Escribano, L.3
Longley, B.J.4
Li, C.Y.5
Schwartz, L.B.6
-
4
-
-
0009013631
-
Somatic c-KIT-activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
-
Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, et al. Somatic c-KIT-activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-4.
-
(1996)
Nat Genet
, vol.12
, pp. 312-314
-
-
Longley, B.J.1
Tyrrell, L.2
Lu, S.Z.3
Ma, Y.S.4
Langley, K.5
Ding, T.G.6
-
5
-
-
0030814553
-
Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis
-
Horny HP, Ruck P, Krober SM, Kaiserling E. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis. Histol Histopathol 1997;12:1081-9.
-
(1997)
Histol Histopathol
, vol.12
, pp. 1081-1089
-
-
Horny, H.P.1
Ruck, P.2
Krober, S.M.3
Kaiserling, E.4
-
6
-
-
0030792218
-
Mastocytosis: Reactive or neoplastic?
-
Krober SM, Horny HP, Ruck P, Kammerer U, Geiselhart A, Handgretinger R, et al. Mastocytosis: reactive or neoplastic? J Clin Pathol 1997;50:525-7.
-
(1997)
J Clin Pathol
, vol.50
, pp. 525-527
-
-
Krober, S.M.1
Horny, H.P.2
Ruck, P.3
Kammerer, U.4
Geiselhart, A.5
Handgretinger, R.6
-
7
-
-
0012083046
-
Staging of systemic mastocytosis: Bone marrow scintigraphy, cytology and bone scan, a preliminary study
-
Caillat-Vigneron N, Lortholary O, Guillevin L, Raphaël M, Casassus P. Staging of systemic mastocytosis: bone marrow scintigraphy, cytology and bone scan, a preliminary study [abstract]. Blood 1994;84(suppl 1):2504.
-
(1994)
Blood
, vol.84
, Issue.SUPPL. 1
, pp. 2504
-
-
Caillat-Vigneron, N.1
Lortholary, O.2
Guillevin, L.3
Raphaël, M.4
Casassus, P.5
-
8
-
-
13044305857
-
Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis
-
Longley BJ, Metcalfe DD, Tharp M, Wang X, Tyrell L, Lu SZ, et al. Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999;96:1609-14.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 1609-1614
-
-
Longley, B.J.1
Metcalfe, D.D.2
Tharp, M.3
Wang, X.4
Tyrell, L.5
Lu, S.Z.6
-
10
-
-
0000948242
-
Anaesthetic management of systemic mastocytosis: Experience with 42 cases
-
Parris WCV, Scott HW, Smith BE. Anaesthetic management of systemic mastocytosis: experience with 42 cases. Anaesth Analg 1986;65:S117.
-
(1986)
Anaesth Analg
, vol.65
-
-
Parris, W.C.V.1
Scott, H.W.2
Smith, B.E.3
-
11
-
-
0025073527
-
Anaesthetic management of systemic mastocytosis
-
Lerno G, Slaats G, Coenen E, Herregods L, Rolly G. Anaesthetic management of systemic mastocytosis. Br J Anaesth 1990;65:254-7.
-
(1990)
Br J Anaesth
, vol.65
, pp. 254-257
-
-
Lerno, G.1
Slaats, G.2
Coenen, E.3
Herregods, L.4
Rolly, G.5
-
12
-
-
0018687287
-
Oral disodium cromoglycate in the treatment of systemic mastocytosis
-
Solter NS, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301:465-9.
-
(1979)
N Engl J Med
, vol.301
, pp. 465-469
-
-
Solter, N.S.1
Austen, K.F.2
Wasserman, S.I.3
-
13
-
-
0019843315
-
Urticaria pigmentosa: Clinical picture and response to oral disodium cromoglycate
-
Czarnetzki BM, Behrendt H. Urticaria pigmentosa: Clinical picture and response to oral disodium cromoglycate. Br J Dermatol 1981;105:563-7.
-
(1981)
Br J Dermatol
, vol.105
, pp. 563-567
-
-
Czarnetzki, B.M.1
Behrendt, H.2
-
15
-
-
0019276489
-
Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists
-
Johnson GJ, Silvis SE, Roitman B, Blumenthal M, Gilbert H. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists. Am J Gastroenterol 1980;74:485-9.
-
(1980)
Am J Gastroenterol
, vol.74
, pp. 485-489
-
-
Johnson, G.J.1
Silvis, S.E.2
Roitman, B.3
Blumenthal, M.4
Gilbert, H.5
-
17
-
-
0018957223
-
The effect of cimetidine and propentheline on the symptoms of a patient with systemic mastocytosis
-
Achord JL, Langford H. The effect of cimetidine and propentheline on the symptoms of a patient with systemic mastocytosis. Am J Med 1980;69:610-4.
-
(1980)
Am J Med
, vol.69
, pp. 610-614
-
-
Achord, J.L.1
Langford, H.2
-
18
-
-
0021907622
-
Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: Results of a double blind trial
-
Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: results of a double blind trial. Am J Med 1985;78:9-14.
-
(1985)
Am J Med
, vol.78
, pp. 9-14
-
-
Frieri, M.1
Alling, D.W.2
Metcalfe, D.D.3
-
19
-
-
0018769542
-
Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis
-
Hirschowitz BI, Groarke JF. Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 1979;90:769-71.
-
(1979)
Ann Intern Med
, vol.90
, pp. 769-771
-
-
Hirschowitz, B.I.1
Groarke, J.F.2
-
20
-
-
0031398769
-
Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis
-
Kurosawa M, Kanbe N, Yamashita T, Miyachi Y. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. J Allergy Clin Immunol 1997;100:S25-32.
-
(1997)
J Allergy Clin Immunol
, vol.100
-
-
Kurosawa, M.1
Kanbe, N.2
Yamashita, T.3
Miyachi, Y.4
-
21
-
-
0029848806
-
The tolerability and safety profile of famotidine
-
Howden CW, Tytgat GNJ. The tolerability and safety profile of famotidine. Clin Ther 1996;18:36-54.
-
(1996)
Clin Ther
, vol.18
, pp. 36-54
-
-
Howden, C.W.1
Tytgat, G.N.J.2
-
22
-
-
0027241041
-
Safety issues relating to long-term treatment with histamine H2-receptor antagonists
-
Sabesin SM. Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Aliment Pharmacol Ther 1993;7(suppl 2):35-40.
-
(1993)
Aliment Pharmacol Ther
, vol.7
, Issue.SUPPL. 2
, pp. 35-40
-
-
Sabesin, S.M.1
-
23
-
-
0020660043
-
A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa
-
Czarnetzki BM. A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 1983;166:44-7.
-
(1983)
Dermatologica
, vol.166
, pp. 44-47
-
-
Czarnetzki, B.M.1
-
25
-
-
0024355259
-
A double-blind., placebo-controlled, cross-over trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis
-
Kettelhut BV, Berkebile C, Bradley D, Metcalfe DD. A double-blind., placebo-controlled, cross-over trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol 1989;83:866-70.
-
(1989)
J Allergy Clin Immunol
, vol.83
, pp. 866-870
-
-
Kettelhut, B.V.1
Berkebile, C.2
Bradley, D.3
Metcalfe, D.D.4
-
26
-
-
0023260179
-
Osteopenia in systemic mastocytosis: Natural history and responses to treatment with inhibitors of bone resorption
-
Cundy T, Beneton MNC, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987;8:149-55.
-
(1987)
Bone
, vol.8
, pp. 149-155
-
-
Cundy, T.1
Beneton, M.N.C.2
Darby, A.J.3
Marshall, W.J.4
Kanis, J.A.5
-
27
-
-
0030841035
-
The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis
-
Marshall A, Kavanagh RT, Crisp AJ. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 1997;39:393-6.
-
(1997)
Br J Rheumatol
, vol.39
, pp. 393-396
-
-
Marshall, A.1
Kavanagh, R.T.2
Crisp, A.J.3
-
28
-
-
0036128440
-
Osteoporosis and bone marrow mastocytosis: Dissociation of skeletal responses and mast cell activity during long-term bisphophonate therapy
-
Brumsen C, Hamdy NAT, Papapoulos SE. Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphophonate therapy. J Bone miner Res 2002;17:567-9.
-
(2002)
J Bone Miner Res
, vol.17
, pp. 567-569
-
-
Brumsen, C.1
Hamdy, N.A.T.2
Papapoulos, S.E.3
-
29
-
-
0026695463
-
Radiation therapy in a case of systemic mastocytosis: Evaluation of histamine levels and mucosal effects
-
Janjan NA, Conway P, Ludberg J, Derfus G. Radiation therapy in a case of systemic mastocytosis: evaluation of histamine levels and mucosal effects. Am J Clin Oncol 1992;15:337-9.
-
(1992)
Am J Clin Oncol
, vol.15
, pp. 337-339
-
-
Janjan, N.A.1
Conway, P.2
Ludberg, J.3
Derfus, G.4
-
32
-
-
0030742614
-
Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis
-
Godt O, Proksch E, Streit V, Christophers E. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 1997;195:35-9.
-
(1997)
Dermatology
, vol.195
, pp. 35-39
-
-
Godt, O.1
Proksch, E.2
Streit, V.3
Christophers, E.4
-
33
-
-
0021237539
-
Reponse of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations
-
Kolde G, Frosch PJ, Czametzki BM. Reponse of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural and biochemical investigations. J Invest Dermatol 1984;83:175-8.
-
(1984)
J Invest Dermatol
, vol.83
, pp. 175-178
-
-
Kolde, G.1
Frosch, P.J.2
Czametzki, B.M.3
-
35
-
-
0025921183
-
The treatment of mastocytosis: An overview
-
Metcalfe DD. The treatment of mastocytosis: an overview. J Invest Dermatol 1991;96:55S-9S.
-
(1991)
J Invest Dermatol
, vol.96
-
-
Metcalfe, D.D.1
-
36
-
-
0025896624
-
Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: A preliminary study
-
Friedman BS, Metcalfe DD. Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study. Clin Exp Allergy 1991;21:183-8.
-
(1991)
Clin Exp Allergy
, vol.21
, pp. 183-188
-
-
Friedman, B.S.1
Metcalfe, D.D.2
-
37
-
-
0025978296
-
Urticaria pigmentosa
-
Guzzo C, Lavker R, Roberts J, Fox K, Schechter N, Lazarus G. Urticaria pigmentosa. Arch Dermatol 1991;127:191-6.
-
(1991)
Arch Dermatol
, vol.127
, pp. 191-196
-
-
Guzzo, C.1
Lavker, R.2
Roberts, J.3
Fox, K.4
Schechter, N.5
Lazarus, G.6
-
38
-
-
0030870541
-
Oral budesonide is as effective as prednisolone in active Crohn's disease
-
Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG, the global budesonide study group. Oral budesonide is as effective as prednisolone in active Crohn's disease. Gut 1997;41:209-14.
-
(1997)
Gut
, vol.41
, pp. 209-214
-
-
Campieri, M.1
Ferguson, A.2
Doe, W.3
Persson, T.4
Nilsson, L.G.5
-
39
-
-
0027997229
-
A comparison of budesonide with prednisolone for active Crohn's disease
-
Rutgeerts P, Löfberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994;331:842-5.
-
(1994)
N Engl J Med
, vol.331
, pp. 842-845
-
-
Rutgeerts, P.1
Löfberg, R.2
Malchow, H.3
Lamers, C.4
Olaison, G.5
Jewell, D.6
-
40
-
-
0032988024
-
Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis
-
Kurosawa M, Amano H, Kanbe N, Igarashi Y, Nagata H, Yamashita T, et al. Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis. J Allergy Clin Immunol 1999;103:S412-20.
-
(1999)
J Allergy Clin Immunol
, vol.103
-
-
Kurosawa, M.1
Amano, H.2
Kanbe, N.3
Igarashi, Y.4
Nagata, H.5
Yamashita, T.6
-
41
-
-
0028899220
-
Interferon-α in combination with corticosteroids improve systemic mast cell disease
-
Delaporte E, Pierard E, Wolthers BG, Desreumaux P, Janin A, Cortot A, et al. Interferon-α in combination with corticosteroids improve systemic mast cell disease. Br J Dermatol 1995;132:479-82.
-
(1995)
Br J Dermatol
, vol.132
, pp. 479-482
-
-
Delaporte, E.1
Pierard, E.2
Wolthers, B.G.3
Desreumaux, P.4
Janin, A.5
Cortot, A.6
-
42
-
-
0025854383
-
Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients
-
Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients. Ann Intern Med 1991;114:532-8.
-
(1991)
Ann Intern Med
, vol.114
, pp. 532-538
-
-
Talpaz, M.1
Kantarjian, H.2
Kurzrock, R.3
Trujillo, J.M.4
Gutterman, J.U.5
-
43
-
-
0034353292
-
Effects of interferon-a2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis
-
Schernthaner GH, Spanblöchl E, Sperr WR, Sillaber C, Semper H, Jurecka W, et al. Effects of interferon-a2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis. Ann Hematol 2000;79:660-6.
-
(2000)
Ann Hematol
, vol.79
, pp. 660-666
-
-
Schernthaner, G.H.1
Spanblöchl, E.2
Sperr, W.R.3
Sillaber, C.4
Semper, H.5
Jurecka, W.6
-
44
-
-
0026570013
-
Response to interferon alpha-2b in a patient with systemic mastocytosis
-
Kluin-Nelemans HC, Jansen JH, Breukelman H, Wolthers BG, Kluin PM, Kroon HM, et al. Response to interferon alpha-2b in a patient with systemic mastocytosis. N Engl J Med 1992;326:619-23.
-
(1992)
N Engl J Med
, vol.326
, pp. 619-623
-
-
Kluin-Nelemans, H.C.1
Jansen, J.H.2
Breukelman, H.3
Wolthers, B.G.4
Kluin, P.M.5
Kroon, H.M.6
-
45
-
-
0032539359
-
Interféron alpha et pamidronate: Une association intéressante dans le traitement des localisations osseuses de la mastocytose systémique
-
Brunel V, Tadrist Z, Cailleres T, Allegre T, Blanc AP. Interféron alpha et pamidronate: une association intéressante dans le traitement des localisations osseuses de la mastocytose systémique. Presse Méd 1998;18:64.
-
(1998)
Presse Méd
, vol.18
, pp. 64
-
-
Brunel, V.1
Tadrist, Z.2
Cailleres, T.3
Allegre, T.4
Blanc, A.P.5
-
46
-
-
0031870101
-
Systemic mastocytosis with extensive polypoid lesion in the intestines, successful treatment with interferon-α
-
Takasaki Y, Tsukasaki K, Jubashi T, Tomonaga M, Kamihira S, Makiyama K. Systemic mastocytosis with extensive polypoid lesion in the intestines, successful treatment with interferon-α. Intern Med 1998;37:484-8.
-
(1998)
Intern Med
, vol.37
, pp. 484-488
-
-
Takasaki, Y.1
Tsukasaki, K.2
Jubashi, T.3
Tomonaga, M.4
Kamihira, S.5
Makiyama, K.6
-
47
-
-
0031943841
-
Response of severe systemic mastocytosis to interferon alpha
-
Butterfield JH. Response of severe systemic mastocytosis to interferon alpha. Br j Dermatol 1998;138:489-95.
-
(1998)
Br J Dermatol
, vol.138
, pp. 489-495
-
-
Butterfield, J.H.1
-
49
-
-
0345772088
-
Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria
-
Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003;27:635-41.
-
(2003)
Leuk Res
, vol.27
, pp. 635-641
-
-
Valent, P.1
Akin, C.2
Sperr, W.R.3
Escribano, L.4
Arock, M.5
Horny, H.P.6
-
50
-
-
0036454699
-
Treatment of adult systemic mastocytosis with interferon-alpha: Results of a multicenter phase II trial on 20 patients
-
Casassus P, Caillat-Vigneron, Martin A, Simon J, Gallais V, Beaudry P, et al. Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicenter phase II trial on 20 patients. Br J Hematol 2002;119:1-8.
-
(2002)
Br J Hematol
, vol.119
, pp. 1-8
-
-
Casassus, P.1
Caillat-Vigneron2
Martin, A.3
Simon, J.4
Gallais, V.5
Beaudry, P.6
-
51
-
-
0035797572
-
Paroxetine for the prevention of depression induced by interferon alpha
-
Kraus MR, Schafer A, Scheurlen M. Paroxetine for the prevention of depression induced by interferon alpha. N Engl J Med 2001;345:375-6.
-
(2001)
N Engl J Med
, vol.345
, pp. 375-376
-
-
Kraus, M.R.1
Schafer, A.2
Scheurlen, M.3
-
52
-
-
0345696854
-
Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
-
Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, et al. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. N Engl J Med 1997;337:223-99.
-
(1997)
N Engl J Med
, vol.337
, pp. 223-299
-
-
Guilhot, F.1
Chastang, C.2
Michallet, M.3
Guerci, A.4
Harousseau, J.L.5
Maloisel, F.6
-
53
-
-
0036842301
-
Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma
-
Escribano L, De Oteyza PJ, Nunez R, Orfao A. Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma. Leuk Res 2002;26:1043-6.
-
(2002)
Leuk Res
, vol.26
, pp. 1043-1046
-
-
Escribano, L.1
De Oteyza, P.J.2
Nunez, R.3
Orfao, A.4
-
54
-
-
0033564769
-
Cladribine activity in adult langerhans-cell histiocytosis
-
Saven A, Burian C. Cladribine activity in adult langerhans-cell histiocytosis. Blood 1999;15(93):4125-30.
-
(1999)
Blood
, vol.15
, Issue.93
, pp. 4125-4130
-
-
Saven, A.1
Burian, C.2
-
55
-
-
0034992599
-
Myelomastocytic overlap syndromes: Biology, criteria, and relationship to mastocytosis
-
Valent P, Sperr WR, Samorapoompichit P, Geissler K, Lechner K, Horny HP, et al. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis. Leuk Res 2001;25:595-602.
-
(2001)
Leuk Res
, vol.25
, pp. 595-602
-
-
Valent, P.1
Sperr, W.R.2
Samorapoompichit, P.3
Geissler, K.4
Lechner, K.5
Horny, H.P.6
-
56
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demetri GD, Von Mehren M, Blanke CD, Van Den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
-
(2002)
N Engl J Med
, vol.347
, pp. 472-480
-
-
Demetri, G.D.1
Von Mehren, M.2
Blanke, C.D.3
Van Den Abbeele, A.D.4
Eisenberg, B.5
Roberts, P.J.6
-
57
-
-
0036493872
-
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutation show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
-
Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutation show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002;99:1741-4.
-
(2002)
Blood
, vol.99
, pp. 1741-1744
-
-
Ma, Y.1
Zeng, S.2
Metcalfe, D.D.3
Akin, C.4
Dimitrijevic, S.5
Butterfield, J.H.6
-
58
-
-
0344987886
-
The effect of tyrosine kinase inhibitor ST1571 on the kinase activity of wild type and various mutated c-kit receptor found in mast cells neoplasms
-
Zermati Y, de Sepulveda P, Létard F, Kersual J, Castéran N, Gorochov G, et al. The effect of tyrosine kinase inhibitor ST1571 on the kinase activity of wild type and various mutated c-kit receptor found in mast cells neoplasms. Oncogene 2003;22:660-4.
-
(2003)
Oncogene
, vol.22
, pp. 660-664
-
-
Zermati, Y.1
De Sepulveda, P.2
Létard, F.3
Kersual, J.4
Castéran, N.5
Gorochov, G.6
|